
Selective targeting of FAK–Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells
Keywords: α-Naphthoflavone; Doxorubicin; Chemotherapeutic resistance; Breast cancer; Focal adhesion kinaseANF, alpha-naphthoflavone; BCa, breast cancer; CI, combination index; Cy, cyanine; DMSO, dimethyl sulfoxide; Dox, doxorubicin; FAK, focal adhesion kinase; P-gp